Future Developments

Axela has developed its core flow through array technology to be compatible with a wide variety of testing formats including plate based automation, random access clinical analyzers and point of use cartridge based diagnostics. The technology also provides advantages in preparation of complex clinical samples for nucleic acid analysis enabling fully automated sample to answer solutions. The highly efficient capture process combined with ultra sensitive detection makes for rapid assays that require minimal sample amounts and simplified instrumentation. The technology encompasses a wide range of protein and nucleic acid analytes and can adapted to fit a partners specific assay requirements.

Please contact Paul Smith directly for information about our development and licensing programs at paul.smith@axela.com